Role of prostaglandins in fibroblast activation and fibrosis

[1]  S. Parapuram,et al.  mPGES-1 null mice are resistant to bleomycin-induced skin fibrosis , 2011, Arthritis research & therapy.

[2]  M. Kapoor,et al.  Loss of peroxisome proliferator-activated receptor gamma in mouse fibroblasts results in increased susceptibility to bleomycin-induced skin fibrosis. , 2009, Arthritis and rheumatism.

[3]  S. Narumiya.  Prostanoids and inflammation: a new concept arising from receptor knockout mice , 2009, Journal of Molecular Medicine.

[4]  G. FitzGerald,et al.  COX-2-derived prostacyclin protects against bleomycin-induced pulmonary fibrosis. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[5]  P. Christmas,et al.  Revisiting prostacyclin: new directions in pulmonary fibrosis and inflammation. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[6]  Rajesh C. Dash,et al.  Prostacyclin protects against elevated blood pressure and cardiac fibrosis. , 2005, Cell metabolism.

[7]  Makoto Murakami,et al.  Reduced Pain Hypersensitivity and Inflammation in Mice Lacking Microsomal Prostaglandin E Synthase-1* , 2004, Journal of Biological Chemistry.

[8]  T. Lawrence,et al.  Inducible cyclooxygenase‐derived 15deoxy Δ 12‐14PGJ2 brings about acute inflammatory resolution in rat pleurisy by inducing neutrophil and macrophage apoptosis , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  D. Abraham,et al.  Prostacyclin derivatives prevent the fibrotic response to TGFβ2 by inhibiting the Ras/MEK/ERK pathway , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  S. Narumiya,et al.  Function of prostanoid receptors: studies on knockout mice. , 2002, Prostaglandins & other lipid mediators.

[11]  Seiji Ito,et al.  Identification and characterization of a novel type of membrane-associated prostaglandin E synthase. , 2002, Biochemical and biophysical research communications.

[12]  D. Abraham,et al.  Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients. , 2001, The Journal of clinical investigation.

[13]  Makoto Murakami,et al.  Molecular Identification of Cytosolic Prostaglandin E2 Synthase That Is Functionally Coupled with Cyclooxygenase-1 in Immediate Prostaglandin E2Biosynthesis* , 2000, The Journal of Biological Chemistry.

[14]  R. Goldstein,et al.  Regulation of connective tissue growth factor expression by prostaglandin E(2). , 1999, The American journal of physiology.

[15]  B. Samuelsson,et al.  Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[16]  William L. Smith,et al.  Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2* , 1996, The Journal of Biological Chemistry.

[17]  T. Grosser,et al.  PROSTANOIDS IN HEALTH AND DISEASE , 1979 .

[18]  J. Vane,et al.  Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis. , 1978, British medical bulletin.